What Is GPNMB and Why Is It Scientifically Important?

GPNMB (Glycoprotein Non-Metastatic Melanoma Protein B), also known as osteoactivin, DC-HIL, and HGFIN, is a type I transmembrane glycoprotein encoded by the GPNMB gene. It is expressed in multiple tissues including melanocytes, osteoclasts, dendritic cells, neurons, and various tumor cell types.

GPNMB plays roles in cell adhesion, migration, and differentiation. It has garnered significant research interest due to its overexpression in aggressive cancers such as triple-negative breast cancer, glioblastoma, and melanoma, making it a validated target for antibody-drug conjugate (ADC) therapy. In neuroscience, GPNMB has been linked to neuroprotective signaling and has been studied in the context of Parkinson's disease and other neurodegenerative conditions. Its extracellular domain mediates interactions with integrins and CD44, influencing downstream signaling cascades relevant to tumor progression and immune modulation.

Product Specifications and Quality Attributes

Aladdin Scientific offers Recombinant Human GPNMB Protein (SKU: rp365780) as a high-quality research reagent. The product is referenced against the absea catalog entry PP-1393, ensuring traceability to a characterized source preparation.

Key quality attributes typically associated with recombinant GPNMB extracellular domain proteins include:

• Expression system: Commonly expressed in mammalian (HEK293 or CHO) cells to preserve native glycosylation patterns critical for functional studies, though the exact expression system for this lot should be confirmed on the datasheet.
• Purity: Research-grade recombinant proteins of this class are typically >90% purity as determined by SDS-PAGE; confirm exact purity on the Certificate of Analysis (CoA).
• Formulation: Usually supplied in a carrier protein-containing buffer (e.g., PBS with BSA) or lyophilized; refer to the product datasheet for the specific formulation.
• Biological activity: Functional activity may be assessed by cell-based adhesion assays or binding assays with known interaction partners such as integrins.

Note: Specific lot-dependent values for purity, endotoxin level, and activity should always be verified against the CoA provided with each shipment.

Storage, Reconstitution, and Handling Guidelines

Proper handling of Recombinant Human GPNMB Protein is essential to maintain its integrity and biological activity. The following general guidelines apply to recombinant proteins of this class; always cross-reference with the specific product datasheet.

• Storage temperature: Lyophilized protein should be stored at -20°C or -80°C in a frost-free freezer. Reconstituted protein aliquots should be stored at -80°C to avoid repeated freeze-thaw cycles.
• Reconstitution: Reconstitute lyophilized protein in sterile deionized water or PBS to the concentration recommended on the datasheet. Allow the vial to equilibrate to room temperature before reconstitution. Gently mix; do not vortex.
• Carrier protein: Adding a carrier protein such as 0.1% BSA is recommended for long-term stability of reconstituted protein at low concentrations.
• Avoid repeated freeze-thaw: Aliquot reconstituted protein into single-use volumes to prevent activity loss.
• Shelf life: Typically 12 months from date of receipt when stored correctly; verify on the datasheet.

Common Research Applications of Recombinant Human GPNMB Protein

Recombinant Human GPNMB Protein is employed across a range of in vitro and in vivo experimental contexts. Representative applications include:

• ELISA and immunoassay development: Used as a standard or coating antigen for development and validation of GPNMB detection assays.
• Binding and interaction studies: Characterizing molecular interactions between GPNMB and binding partners such as CD44, syndecans, and integrins using surface plasmon resonance (SPR) or bio-layer interferometry (BLI).
• Cell-based functional assays: Stimulation of cell lines to study downstream signaling pathways including ERK/MAPK and PI3K/AKT cascades activated by GPNMB.
• Antibody screening and validation: As an antigen to screen hybridoma supernatants or validate antibody specificity in Western blot and flow cytometry applications.
• Drug target research: Supporting preclinical studies related to ADC development (e.g., glembatumumab vedotin target validation) and small molecule inhibitor screening.
• Neuroscience and neurodegeneration research: Investigating neuroprotective roles of GPNMB in cellular models of Parkinson's disease and lysosomal storage disorders.